These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10088627)

  • 1. p53 and genetic susceptibility to cervical cancer.
    Sonoda Y; Saigo PE; Boyd J
    J Natl Cancer Inst; 1999 Mar; 91(6):557. PubMed ID: 10088627
    [No Abstract]   [Full Text] [Related]  

  • 2. Papillomavirus and p53 codon 72 polymorphism.
    Bertorelle R; Chieco-Bianchi L; Del Mistro A
    Int J Cancer; 1999 Aug; 82(4):616-7. PubMed ID: 10404080
    [No Abstract]   [Full Text] [Related]  

  • 3. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
    Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
    Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.
    Ngan HY; Tsao SW; Liu SS; Stanley M
    Genitourin Med; 1997 Feb; 73(1):54-8. PubMed ID: 9155557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility to HPV infection and cervical cancer.
    Maciag PC; Villa LL
    Braz J Med Biol Res; 1999 Jul; 32(7):915-22. PubMed ID: 10454752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia.
    Rosenthal AN; Ryan A; Hopster D; Jacobs IJ
    Br J Cancer; 2000 Nov; 83(10):1287-90. PubMed ID: 11044351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-related cancer susceptibility and p53 codon 72 polymorphism.
    Gustafsson AC; Guo Z; Hu X; Ahmadian A; Brodin B; Nilsson A; Pontén J; Pontén F; Lundeberg J
    Acta Derm Venereol; 2001 May; 81(2):125-9. PubMed ID: 11501650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 codon 72 polymorphism and human papillomavirus associated skin cancer.
    O'Connor DP; Kay EW; Leader M; Atkins GJ; Murphy GM; Mabruk MJ
    J Clin Pathol; 2001 Jul; 54(7):539-42. PubMed ID: 11429426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.
    Tachezy R; Mikysková I; Saláková M; Van Ranst M
    Hum Genet; 1999 Dec; 105(6):564-6. PubMed ID: 10647890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.
    Assoumou SZ; Boumba AL; Ndjoyi-Mbiguino A; Khattabi A; Ennaji MM
    Med Oncol; 2015 Jan; 32(1):281. PubMed ID: 25502079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
    Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
    Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in carcinogenesis of cervical cancer.
    de Silva NR; Mendis L; Perera N
    Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100
    [No Abstract]   [Full Text] [Related]  

  • 14. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
    Sun Y; Si L
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):29-32. PubMed ID: 7781112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
    Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
    Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codon 72 polymorphism of p53 and its association with cervical cancer.
    Zehbe I; Voglino G; Wilander E; Genta F; Tommasino M
    Lancet; 1999 Jul; 354(9174):218-9. PubMed ID: 10421306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
    Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
    Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.
    Storey A; Thomas M; Kalita A; Harwood C; Gardiol D; Mantovani F; Breuer J; Leigh IM; Matlashewski G; Banks L
    Nature; 1998 May; 393(6682):229-34. PubMed ID: 9607760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
    Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new link between Fanconi anemia and human papillomavirus-associated malignancies.
    Lowy DR; Gillison ML
    J Natl Cancer Inst; 2003 Nov; 95(22):1648-50. PubMed ID: 14625250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.